Effect of dexamethasone on insulin receptor mRNA levels, RNA stability and isotype RNA pattern in U-937 human promonocytic cells

Journal of Endocrinological Investigation

Volumn 19, Issue 8, 1996, Pages 530-534

  Leal, M A ^a   Aller, P ^b   Calle, C ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Dexamethasone; Insulin receptor gene expression; Insulin receptor isotypes; U 937 cells

Indexed keywords

CYCLOHEXIMIDE; DEXAMETHASONE; INSULIN RECEPTOR; ISOPROTEIN; MESSENGER RNA; RECEPTOR SUBTYPE; RNA;

ARTICLE; CELL LINE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MONOCYTE; PROTEIN STABILITY; RECEPTOR GENE; STEM CELL;

EID: 0029830287     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349012     Document Type: Article

References (27)

1. Leal M.A., Aller P., Torres A., Picardo A., Dávila N., Calle C. Insulin receptor mRNA levels are modulated in a tissue-specific manner in Cushing's syndrome patients. Horm. Metab. Res. 26: 349, 1994.
2. Leal M.A., Aller P., Mas A., Carranza M.C., Calle C. Tissue-specific changes in insulin receptor mRNA concentrations in dexametasone-treated and adrenalectomized rats. Endocr. J. 41: 737, 1994.
3. Leal M.A., Cabañas C., Rius C., Aller P., Calle C. Modulation by dexamethasone of insulin binding and insulin receptor mRNA levels in U-937 human promonocytic cells. Biochimie 74: 545, 1992.
4. McDonald A.R., Goldfine I.D. Glucocorticoid regulation of insulin receptor gene transcription in IM-9 cultured lymphocytes. J. Clin Invest. 81: 499, 1988.
5. Briata P., Gherzi R. Multifactorial control of insulin receptor gene expression in human cell lines. Biophys. Res. Commun. 170: 1184, 1990.
6. Levy J.R., Krystal G., Glickman P., Dastvan F. Effects of media conditions, insulin, and dexamethasone on insulin-receptor mRNA and promoter activity in HepG2 cells. Diabetes 40: 58, 1991.
7. Sundstrom C., Nilsson K. Establishment and characterization of a human histocytic lymphoma cell line (U-937). Int. J. Cancer 17: 565, 1976.
8. Robert A., Grunberger G., Carpentier J.L., Dayer J.M., Orci L., Gorden P. The insulin receptor of a human monocyte-like cell line: characterization and function. Endocrinology 114: 247, 1984.
9. Seino S., Bell G.I. Alternative splicing of human insulin receptor messenger RNA. Biophys. Res. Commun. 159: 312, 1989.
10. Moller D.E., Yokota A., Caro J.F., Flier J.S. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol. Endocrinol. 3: 1263, 1989.
11. Kosaki A., Webster N.J.G. Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. J. Biol. Chem. 268: 21990, 1993.
12. Norgren S., Luthman H. Regulation of human insulin receptor RNA splicing in HepG2 cells: Effects of glucocorticoid and low glucose concentration. Biophys. Res. Commun. 199: 277, 1994.
13. Aller P., Rius C., Mata F., Zorrilla A., Cabañas C., Bellón T., Bernabeu C. Camptothecin induces differentiation and stimulates the expression of differentiation related genes in U-937 human promonocytic leukemia cells. Cancer Res. 52: 1245, 1992.
14. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156, 1987.
15. Lebrach H., Diamond D., Wozney M., Boetzke H RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry 16: 4743, 1977.
16. Hirschhorn R.R., Aller P., Yuan Z.A., Gibson C.W., Baserga R. Cell-cycle specific cDNAs from mammalian cells temperature sensitive for growth. Proc. Natl. Acad. Sci. USA 81: 6004, 1984.
17. Ullrich A., Bell J.R., Chen E.Y ., Herrera R., Petruzelli L.M., Dull T.J., Gray A., Coussens L., Liao Y.C., Tsubokawa M., Mason A., Seeburg P.H., Grunfeld C., Rosen O.M., Ramachandran J. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313: 756, 1985.
18. Alonso S., Minty A., Borlet Y., Buckingham M. Comparison of three actin-coding sequences in the mouse: evolutionary relationships between actin genes of warmblooded vertebrates. J. Mol. Evol. 23: 1, 1986.
19. Feinberg A.P., Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137: 266, 1984 .
20. Iwama N., Nomura M., Kajimoto Y., Imano E., Kubota M., Watarai T., Kawamori R., Shichiri M., Kamada T. Effect of dexamethasone on the synthesis and degradation of insulin receptor mRNA in cultured IM-9 cells. Diabetologia 30: 899, 1987.
21. Rouiller D.G., McKeon C., Taylor S.I., Gorden P. Hormonal regulation of insulin receptor gene expression. Hydrocortisone and insulin act by different mechanisms. J. Biol. Chem. 263: 13185, 1988.
22. Levy J.R., Hug V. Regulation of insulin receptor gene expression. Cell cycle-mediated effects on insulin receptor mRNA stability. J. Biol. Chem. 267: 25289, 1992.
23. Tewari M., Tewari D.S., Taub R. Posttranscriptional mechanisms account for differences in steady state levels of insulin receptor messenger RNA in different cells. Mol. Endocrinol. 5: 653, 1991.
24. Lee J-K., Tsai S.Y. Multiple hormone response elements can confer glucocorticoid regulation on the human insulin receptor gene. Mol. Endocrinol. 8: 625, 1994.
25. Rius C., Aller P. Modulation of ornithine decarboxylase gene transcript levels by differentiation induced in human promyelocytic leukemia HI-60 cells. Cell Differ. Dev. 28: 39, 1989.
26. 3 or by retinoic acid. Opposite effects on insulin receptors. Exp. Cell Res. 157: 539, 1985.
27. 3 on insulin binding, insulin receptor mRNA levels and isotype RNA pattern in U-937 human promonocytic cells. Exp. Cell Res. 217: 189, 1995.